181 related articles for article (PubMed ID: 30391672)
1. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
Free Radic Biol Med; 2019 Jan; 130():256-266. PubMed ID: 30391672
[TBL] [Abstract][Full Text] [Related]
2. FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cells.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
Life Sci; 2021 Feb; 267():118952. PubMed ID: 33383048
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 9 Suppresses Striatal Cell Death Dominantly Through ERK Signaling in Huntington's Disease.
Yusuf IO; Cheng PH; Chen HM; Chang YF; Chang CY; Yang HI; Lin CW; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
Cell Physiol Biochem; 2018; 48(2):605-617. PubMed ID: 30021209
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.
Oliveira AM; Cardoso SM; Ribeiro M; Seixas RS; Silva AM; Rego AC
Neurochem Int; 2015 Dec; 91():1-12. PubMed ID: 26476055
[TBL] [Abstract][Full Text] [Related]
5. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
6. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation.
Chuang JI; Huang JY; Tsai SJ; Sun HS; Yang SH; Chuang PC; Huang BM; Ching CH
Free Radic Biol Med; 2015 Dec; 89():274-86. PubMed ID: 26424114
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease Models.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
Mol Neurobiol; 2021 May; 58(5):2396-2406. PubMed ID: 33421017
[TBL] [Abstract][Full Text] [Related]
8. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
Choudhury KR; Das S; Bhattacharyya NP
J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 9 reduces TBHP-induced oxidative stress in chondrocytes and diminishes mouse osteoarthritis by activating ERK/Nrf2 signaling pathway.
Pan YN; Jia C; Yu JP; Wu ZW; Xu GC; Huang YX
Int Immunopharmacol; 2023 Jan; 114():109606. PubMed ID: 36700776
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress.
Zhu H; Jia Z; Misra BR; Zhang L; Cao Z; Yamamoto M; Trush MA; Misra HP; Li Y
Cardiovasc Toxicol; 2008; 8(2):71-85. PubMed ID: 18463988
[TBL] [Abstract][Full Text] [Related]
13. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
[TBL] [Abstract][Full Text] [Related]
14. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM
J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674
[TBL] [Abstract][Full Text] [Related]
15. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
[TBL] [Abstract][Full Text] [Related]
16. Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington's disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors.
Jang M; Choi JH; Chang Y; Lee SJ; Nah SY; Cho IH
Brain Behav Immun; 2019 Aug; 80():146-162. PubMed ID: 30853569
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma-glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity.
Huang JY; Chuang JI
Free Radic Biol Med; 2010 Sep; 49(6):1099-108. PubMed ID: 20615462
[TBL] [Abstract][Full Text] [Related]
18. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway.
Colín-González AL; Luna-López A; Königsberg M; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2014 Feb; 260():130-9. PubMed ID: 24361737
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway.
Wang B; Liu H; Yue L; Li X; Zhao L; Yang X; Wang X; Yang Y; Qu Y
Brain Res; 2016 Jul; 1643():70-9. PubMed ID: 27107941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
